Table 2 |
||
|
Comparison of Glasgow Outcome Scale scores between the progesterone and placebo groups patients at 3-month and 6-month follow-up |
||
|
Glasgow Outcome Scale scores |
Progesterone (n = 82) |
Placebo (n = 77) |
|
|
||
|
3 months |
||
|
Good recovery |
21 (25) |
10 (12) |
|
Moderate disability |
18 (21) |
14 (18) |
|
Severe disability |
16 (19) |
13 (16) |
|
Vegetative survival |
13 (15) |
16 (20) |
|
Death |
15 (18) |
25 (32) |
|
6 months |
||
|
Good recovery |
26 (31) |
19 (24) |
|
Moderate disability |
22 (26) |
14 (18) |
|
Severe disability |
9 (10) |
11 (14) |
|
Vegetative survival |
10 (12) |
8 (10) |
|
Death |
15 (18) |
25 (32) |
|
|
||
|
Data presented as n (%). |
||
|
Xiao et al. Critical Care 2008 12:R61 doi:10.1186/cc6887 |
||